NCT00263393

Brief Summary

This study will evaluate the effectiveness of a novel cardiovascular disease prevention program designed for delivery through existing primary health care services in rural villages in Andhra Pradesh. The primary aim is to increase the number of high-risk individuals in the population that are appropriately managed with proven, low-cost preventive interventions. The corresponding null hypothesis is therefore that the prevention program will result in no change in the proportion of high-risk individuals identified and treated in villages assigned to intervention compared with those villages assigned to control.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,712

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Dec 2005

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2005

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

December 6, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 8, 2005

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2009

Completed
Last Updated

September 12, 2018

Status Verified

September 1, 2018

Enrollment Period

3 years

First QC Date

December 6, 2005

Last Update Submit

September 10, 2018

Conditions

Keywords

Myocardial InfarctionAngina PectorisCerebrovascular AccidentDiabetes MellitusCluster randomized designCommunity-based intervention trialPrimary Healthcare interventionLifestyle advice

Outcome Measures

Primary Outcomes (2)

  • The proportion of high-risk individuals that have been assessed for cardiovascular risk

    12 months after intevention

  • The proportion of individuals with correct knowledge about the effects of behavioural determinants of the risk of cardiovascular disease

    12 months from intervention

Secondary Outcomes (3)

  • The proportion of high risk individuals treated with two or more of the recommended drug therapies

    12 months

  • The knowledge, attitudes and practices of the population about preventable conditions and actions taken to prevent non-communicable disease

    12 months from intervention

  • The risk factor levels of the population identified as high risk.

    12 months

Study Arms (2)

Algorithm-based care

OTHER

An algorithm based approach to increase the identification of high-risk individuals in the community through encouraging opportunistic screening, and to increase the use of appropriate evidence based prevention strategies.

Drug: ASA, Atenolol, hydrochlorothiazide, ACE inhibitor, Statin

Health-promotion

OTHER

The health promotion arm has been designed to increase knowledge of the causes of cardiovascular disease and enhance use of preventive behaviours in the general population

Behavioral: Health Promotion

Interventions

The first intervention was a clinical algorithm designed to enhance the identification and treatment of high-risk individuals compared to continued usual care. The algorithm was designed to be used by either physician or non-physician health care workers.

Algorithm-based care

The second intervention was a health promotion program designed to increase knowledge of cardiovascular risk factors compared to continued usual practices.

Health-promotion

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 30 years and above
  • Personal history of heart attack or stroke
  • Presence of other cardiovascular risk factors such as smoking, overweight, diabetes

You may not qualify if:

  • Mental disability
  • Not living in the Study area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Byrraju Foundation Primary Healthcare Centres in rural West Godavari and East Godavari Dstricts

Bhimavaram, Andhra Pradesh, India

Location

Related Publications (2)

  • Chow CK, Joshi R, Gottumukkala AK, Raju K, Raju R, Reddy S, Macmahon S, Neal B. Rationale and design of the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a factorial, cluster-randomized trial of 2 practical cardiovascular disease prevention strategies developed for rural Andhra Pradesh, India. Am Heart J. 2009 Sep;158(3):349-55. doi: 10.1016/j.ahj.2009.05.034. Epub 2009 Jul 15.

    PMID: 19699856BACKGROUND
  • Joshi R, Chow CK, Raju PK, Raju KR, Gottumukkala AK, Reddy KS, Macmahon S, Heritier S, Li Q, Dandona R, Neal B. The Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS): a cluster randomized trial. J Am Coll Cardiol. 2012 Mar 27;59(13):1188-96. doi: 10.1016/j.jacc.2011.10.901. No abstract available.

MeSH Terms

Conditions

Myocardial InfarctionAngina PectorisStrokeDiabetes Mellitus

Interventions

AtenololHydrochlorothiazideAngiotensin-Converting Enzyme InhibitorsHydroxymethylglutaryl-CoA Reductase InhibitorsHealth Promotion

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisChest PainPainNeurologic ManifestationsSigns and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

PhenoxypropanolaminesPropanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsPropanolsAminesChlorothiazideBenzothiadiazinesSulfonamidesSulfonesSulfur CompoundsThiazidesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsProtease InhibitorsEnzyme InhibitorsMolecular Mechanisms of Pharmacological ActionPharmacologic ActionsChemical Actions and UsesAnticholesteremic AgentsHypolipidemic AgentsAntimetabolitesLipid Regulating AgentsTherapeutic UsesHealth EducationPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Bruce C Neal

    The George Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Fellow

Study Record Dates

First Submitted

December 6, 2005

First Posted

December 8, 2005

Study Start

December 1, 2005

Primary Completion

December 1, 2008

Study Completion

June 1, 2009

Last Updated

September 12, 2018

Record last verified: 2018-09

Locations